Hostname: page-component-7b7567c8c-jswmv Total loading time: 0 Render date: 2026-11-15T14:50:11.380Z Has data issue: false hasContentIssue false
  • English
  • Français

E. coli antibodies in schizophrenia

Published online by Cambridge University Press:  09 July 2009

J. Krøll
J. Krøll*
Affiliation:
From the Finsen Laboratory, The Finsen Institute, Copenhagen, Denmark
*
1Address for correspondence: Dr J. Krøll, The Finsen Laboratory, The Finsen Institute, 49 Strandboulevard, DK-2100 Copenhagen Denmark.
Get accessRights & Permissions [Opens in a new window]

Synopsis

The present investigation demonstrates relatively high antibody titres against an E. coli O-antigen in sera from somatically healthy male schizophrenic patients. This observation supports the suggestion that abnormal portasystemic collaterals are relevant to the manifestation of schizophrenia.

Information

Type
Brief Communication
Information
Psychological Medicine , Volume 16 , Issue 1 , February 1986, pp. 209 - 211
Copyright
Copyright © Cambridge University Press 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Alvarez, R. G. & Kazimierczak, W. (1981). New light on the mechanism of action of disodium cromoglycate. Agents and Actions 11, 94–96.Google Scholar
Buscaino, G. A. (1978). The amino-hepato-entero-toxic theory of schizophrenia: an historical evaluation. In The Biological Basis of Schizophrenia (ed. Hemmings, G. and Hemmings, W. A.), pp. 45–54. MTP Press: Lancaster.CrossRefGoogle Scholar
Dohan, F. C. & Grasberger, J. C. (1973). Relapsed schizophrenics: earlier discharge from the hospital after cereal-free, milk-free diet. American Journal of Psychiatry 130, 685–688.Google Scholar
Galbraith, R. M., Williams, R., Pattison, J., Kennedy, L. A., Eddleston, A. L. W. F., Webster, A. O. B., Doniac, D. & Batchelor, J. T. (1976). Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting. Lancet i, 930–934.CrossRefGoogle Scholar
Hekkens, J. M. (1978). Antibodies to gliadin in serum of normals, coeliac patients and schizophrenics. In The Biological Basis of Schizophrenia (ed. Hemmings, G. and Hemmings, W. A.), pp. 259–261. MTP Press: Lancaster.CrossRefGoogle Scholar
Kashyap, N., Sharma, D. P., Mukhopadhyay, S., Nundy, S. & Bhargava, S. (1983). Evaluation of techniques for assessment of portasystemic shunt patency. Indian Journal of Medical Research 78, 841–846.Google Scholar
Kinnell, H. G., Kirkwood, E. & Lewis, C. (1982). Food antibodies in schizophrenia. Psychological Medicine 12, 85–89.CrossRefGoogle ScholarPubMed
Krøll, J. (1965). Liver dysfunction and schizophrenia. Lancet i, 763–764.CrossRefGoogle Scholar
Krøll, J. (1983). Line immunoelectrophoresis. Scandinavian Journal of Immunology 17, Suppl. 10, 151–163.CrossRefGoogle Scholar
Krøll, J. & Fog, R. (1968). Portal-systemic shunts and mental disorders. Acta Psychiatrica Scandinavica 44, 255–260Google Scholar
Krøll, J., Jensen, K. A. & Lyngbye, J. (1969). Quantitative immunoelectrophoresis as routine analysis. In Methods in Clinical Chemistry, Vol. 1 (ed. Roth, M.), pp. 131–139. S. Karger: Basle.Google Scholar
Martin, L. W. & Bryant, L. R. (1962). The use of fructose to determine the patency of portal-systemic shunts. Archives of Surgery 85, 783–791.CrossRefGoogle Scholar
Mascord, I., Freed, D. & Durrant, B. (1978). Antibodies to foodstuffs in schizophrenia. British Medical Journal ii, 1351.Google Scholar
Prytz, H., Bjørneboe, M., Stæhr Johansen, T. & Ørskov, F. (1974). The influence of portasystemic shunt operation on immunoglobulins and Escheria coli antibodies in patients with cirrhosis of liver. Acta Medico Scandinavica 196, 109–112.CrossRefGoogle Scholar
Triger, D. R., Boyer, T. D., Redeker, A. G., Reynolds, T. B. & Waxman, A. D. (1979). Differences in intrahepatic portal-systemic shunting in alcoholic and nonalcoholic liver disease as assessed by liver scan, portal pressure and E. coli antibodies. Digestive Diseases and Sciences 24 (7), 509–513.Google Scholar
Voorhees, A. B., Chaitman, E., Schneider, S., Nicholson, J. F., Kornfeld, D. S. & Price, J. (1973). Portal-systemic encephalopathy in the non-cirrhotic patient. Effect of portal-systemic shunting. Archives of Surgery 107, 659–663.CrossRefGoogle Scholar